ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "treatment and ultrasound"

  • Abstract Number: 411 • ACR/ARHP Annual Meeting 2017

    Factors That Drive Treatment Recommendation during Rheumatoid Arthritis Patient´s Follow-up, Differ According to Physician Experience

    César Sifuentes-Cantú1, Irazu Contreras-Yañez2, Lina Saldarriaga Rivera3, Ana Cecilia Lozada4, Marwin Gutierrez5 and Virginia Pascual-Ramos1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 3Instituto Nacional de Rehabilitación, Mexico, Mexico, 4Division of musculoskeletal and rheumatic diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico, 5Rheumatology, Instituto Nacional de Rehabilitación, Mexico City, Mexico

    Background/Purpose: The management plan for rheumatoid arthritis (RA) might be a relatively simple task if only disease activity is considered but might become more complex…
  • Abstract Number: 1392 • ACR/ARHP Annual Meeting 2017

    Effect Size Comparison of Ultrasound Measures in Rheumatoid Arthritis

    Veena K. Ranganath1, David Elashoff2, Jenny Brook3, Ami Ben-Artzi4, Geraldine Navarro5, Lynnette Avedikian-Tatosyan6, George Karpouzas7, William Martin5, Tanaz A. Kermani5, Soo Choi5 and Gurjit S. Kaeley8, 1Medicine/Rheumatology, University of California, Los Angeles, Los Angeles, CA, 2David Geffen School of Medicine,, University of California, Los Angeles, Los Angeles, CA, 3Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, 4Medicine, Cedars, Beverly Hills, CA, 5Medicine, Division of Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA, 6Healthcare Partners, Los Angeles, CA, 7Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 8Rheumatology, University of Florida College of Medicine, Jacksonville, Jacksonville, FL

    Background/Purpose: Currently there are several outcome metrics used for the assessment and quantification of musculoskeletal (MSK) ultrasound inflammatory burden in rheumatoid arthritis (RA). This study…
  • Abstract Number: 2013 • ACR/ARHP Annual Meeting 2017

    Physician Experience and Patient´s Disease Activity Affect the Impact of Musculoskeletal Ultrasound on the Treatment Decision in Rheumatoid Arthritis Patients

    César Sifuentes-Cantú1, Irazu Contreras-Yañez2, Marwin Gutierrez3 and Virginia Pascual-Ramos4, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 3Rheumatology, Instituto Nacional de Rehabilitación, Mexico City, Mexico, 4Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: In a real clinical setting of RA outpatients, we previously showed that musculoskeletal ultrasound (MUS) added to clinical evaluation impacted the treatment decision in…
  • Abstract Number: 2967 • ACR/ARHP Annual Meeting 2017

    Adding Ultrasound to the Treat-to-Target Strategy Shows No Benefit in Achievement of Remission: Results from the Biodam Cohort

    Alexandre Sepriano1, Sofia Ramiro2, Robert B.M. Landewé3, Désirée van der Heijde1, Sarah Ohrndorf4, Oliver FitzGerald5, Marina Backhaus6, Maggie Larche7, Joanne Homik8, Alain Saraux9, Hilde B. Hammer10, Lene Terslev11, Mikkel Østergaard11, Gerd R. Burmester12, Bernard Combe13, Maxime Dougados14, Carol A Hitchon15, Gilles Boire16, Robert G. Lambert8, Rana Dadashova17, Joel Paschke18, Edna Hutchings17 and Walter P. Maksymowych17, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 3University of Amsterdam and Atrium Medical Center, Amsterdam, Netherlands, 4Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 5ASRI, Dublin, Ireland, Dublin, Ireland, 6Rheumatology/Immunology, Charite University Hospital, Berlin, Germany, 7Medicine, McMaster University, Hamilton, ON, Canada, 8University of Alberta, Edmonton, AB, Canada, 9Rheumatology Department, Rheumatology Department, CHU de la Cavale Blanche, Brest, France, Brest Cedex, France, 10Dept. of Rheumtology, Diakonhjemmet Hospital, Oslo, Norway, 11Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark, 12Department of Rheumatology and Clinical Immunolgy, Charité University Hospital, Berlin, Germany, 13Rheumatology, Lapeyronie Hospital, Montpellier I university, Montpellier, France, 14Paris-Descartes University,, Paris, France, 15University of Manitoba, Winnipeg, MB, Canada, 16Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 17CaRE Arthritis, Edmonton, AB, Canada, 18CARE Arthritis, Edmonton, AB, Canada

    Background/Purpose: While, a Treat-to-Target strategy (T2T), treating patients with rheumatoid arthritis (RA) towards a certain target (eg. clinical remission; T2T-REM), is highly recommended, several patients…
  • Abstract Number: 100 • Pediatric Rheumatology Symposium 2017

    Improvement of Salivary Gland Ultrasound Findings in Juvenile Sjögren’s Syndrome after Systemic Corticosteroid Treatment

    Akaluck Thatayatikom1, Renee F Modica2, Daniel S. Hammenfors3, Natalie Jane Shiff1 and Melissa E Elder2, 1Pediatrics, University of Florida, Gainesville, FL, 2Department of Pediatrics, University of Florida, Gainesville, FL, 3Department of Rheumatology, Haukeland University Hospital, Bergen, Norway

    Background/Purpose:  Juvenile Sjögren’sSyndrome (jSS) is a rare systemic autoimmune disease affecting predominantly salivary glands (SG) in children who do not meet criteria for SLE or MCTD. Currently, no specific criteria for…
  • Abstract Number: 1977 • ACR/ARHP Annual Meeting 2016

    Impact of Ultrasound in Treatment Decision of Rheumatoid Arthritis Assessed in Routine Clinical Practice

    César Sifuentes-Cantú1, Lina Saldarriaga-Rivera2, Ana Cecilia Lozada2, Irazu Contreras-Yañez3, Marwin Gutierrez4 and Virginia Pascual-Ramos5, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Division of musculoskeletal and rheumatic diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico, 3Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 4Instituto Nacional de Rehabilitación, Mexico, Mexico, 5Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: Remission or low disease activity is the therapeutic target for rheumatoid arthritis (RA). There is a consistent body of evidence supporting the value of…
  • Abstract Number: 1446 • ACR/ARHP Annual Meeting 2014

    Utility of Ultrasound in the Nuffield Orthopaedic Centre Emergency Rheumatology Clinic: Survey of Clinical Effectiveness

    Kuljeet Bhamra1, Catherine Swales1, Matthew Seymour1, Catherine McClinton1 and Peter C. Taylor2, 1Nuffield Department of orthopaedics,rheumatology and musculosketal sciences, University of Oxford, Oxford, United Kingdom, 2NDORMS, Botnar Research Centre, University of Oxford, Oxford, United Kingdom

    Background/Purpose The aim of the survey was to evaluate the impact of clinic-based musculoskeletal ultrasonography (MSUS) on diagnosis and management of cases seen in the…
  • Abstract Number: 798 • ACR/ARHP Annual Meeting 2013

    Targeting Ultrasound Remission In Early Rheumatoid Arthritis – Results Of The Taser Study

    James Dale1, Anne Stirling2, Iain B. McInnes1 and Duncan Porter3, 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 2Gartnavel General Hospital, Glasgow, United Kingdom, 3Rheumatology, Gartnavel General Hospital, Glasgow, United Kingdom

    Background/Purpose: The TaSER study (NCT00920478) is an open label randomized clinical trial with blinded assessments of outcome. It was designed to test whether the efficacy…
  • Abstract Number: 808 • ACR/ARHP Annual Meeting 2012

    Power Doppler Is Predictive of Treatment Failure in Early Rheumatoid Arthritis Patients: A One Year Follow-up Study

    Karine R. Luz1, Rita N.V. Furtado1, Marcelo M. Pinheiro2, Giovanna S. Petterle1 and Jamil Natour1, 1Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil, 2Brazilian Registry of Spondyloarthritis, São Paulo, Brazil

    Background/Purpose: It is known that ultrasound (US) is a useful test to monitor rheumatoid arthritis (RA) patients. However, to date, no study has shown the…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology